Inactive Instrument

Cloud Security Corp Stock OTC Bulletin Board

Equities

US18911V1017

Healthcare Facilities & Services

End-of-day quote OTC Bulletin Board
- USD - Intraday chart for Cloud Security Corp
US China Biomedical Technology : China stocks rise after Sino-U.S. 'candid' talks; Hong Kong gains RE
Safran : Boeing faces rocky path to gaining approval for 737 MAX return in China RE
Analysis: Delay to U.S. China investment ban leaves U.S. investors in limbo RE
Us-China Biomedical Technology, Inc. Reports Earnings Results for the First Quarter Ended May 31, 2019 CI
Us-China Biomedical Technology, Inc. Reports Earnings Results for the Full Year Ended February 28, 2019 CI
US-China Biomedical Technology, Inc. Receives Resignation of Wentie Sun as a Member of the Board CI
Safa Movassaghi Resigns as Vice President and Joins as Member of the Board of US-China Biomedical Technology, Inc CI
Us-China Biomedical Technology, Inc. Reports Earnings Results for the Third Quarter Ended November 30, 2018 CI
US-China Biomedical Reportedly Intends To Seek Acquisitions CI
US-China Biomedical Technology, Inc. Announces Resignation of Rand Scott as Member of the Board CI
US-China Biomedical Technology, Inc. Appoints Safa Movassaghi as Vice President CI
US-China Biomedical Technology, Inc. Appoints Wentie Robert Sun as a Member of Board CI
US-China Biomedical Technology, Inc. Appoints H. Rand Scott as a Member of the Board CI
Cloud Security Corporation will Change its Name to US-China Biomedical Technology, Inc CI
Cloud Security Corporation Announces Resignation of Amanda Huang as Senior Vice President CI
More news
Managers TitleAgeSince
Chief Executive Officer 50 17-07-27
Chief Executive Officer 61 11-10-16
Members of the board TitleAgeSince
Chief Executive Officer 61 11-10-16
Chief Executive Officer 50 17-07-27
More insiders
US-China Biomedical Technology, Inc, formerly Cloud Security Corporation, is focused on integrating and developing synergistic relationships with doctors and hospitals. The Company focuses on developing a scalable biomedical bridge that connects patients and bio-technology advances in China with the Company's network of United States-based doctors and hospitals. The bridge provides concierge and general medical services for patients moving from China to the United States. Its concierge services are for cancer patient referrals that are in non-critical, non-life threatening positions, pre-screening and genetic testing for family members of cancer patients, and patients suffering from diabetes. Its general medical care services also include preventative care and physicals.
More about the company